MARAVAI LIFESCIENCES HOLDINGS, INC.

September 7, 2021

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-1090

 

Attention:

Michael Davis

 

Joe McCann

 

          Re:

Maravai LifeSciences Holdings, Inc.

  

Registration Statement on Form S-1 (File No. 333-259366)

 

Originally Filed September 7, 2021

  

Request for Acceleration of Effective Date

  

CIK: 0001823239

Ladies and Gentlemen:

Maravai LifeSciences Holdings, Inc., a Delaware corporation (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-259366), originally filed on September 7, 2021 (the “Registration Statement”), to 4:00 p.m., Eastern time, on September 9, 2021 or as soon thereafter as practicable.

*        *        *         *


Please contact Robert Goedert, P.C. of Kirkland & Ellis LLP, special counsel to the Company, at (312) 862-7317, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

 

Sincerely,

 

MARAVAI LIFESCIENCES HOLDINGS, INC.

 

By:  

/s/ Carl Hull

Name:   Carl Hull
Title:   Chief Executive Officer